Bookmark
Forward
Explore Literature Results
Explore Clinical Trials Results
QuickView for B cell maturation antigen (gene)
Most Relevant Literature
- Anti-BCMA novel therapies for multiple myeloma.
- Beyond BCMA, why GPRC5D could be the right way: treatment strategies with immunotherapy at relapse a…
- CAR NK92 Cells Targeting BCMA Can Effectively Kill Multiple Myeloma Cells Both In Vitro and In Vivo.
- Targeting BCMA in Multiple Myeloma.
- Bispecific CS1-BCMA CAR-T cells are clinically active in relapsed or refractory multiple myeloma.
Most Relevant Clinical Trials
- Study of T Cells Targeting B-Cell Maturation Antigen for Previously Treated Multiple Myeloma
- B Cell Maturation Antigen（BMCA）-Targeted CAR-T for Refractory/Relapsed Multiple Myeloma
- A Study of LCAR-B38M CAR-T Cells, a Chimeric Antigen Receptor T-cell (CAR-T) Therapy Directed Agains…
- A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell …
- B Cell Maturation Antigen Targeted CAR-T Cells in Treatment With Relapsed and Refractory Multiple My…
